The effect of hepatoheal tablet on non alcoholic fatty liver

The effect of hepatoheal tablet on liver enzymes of patients with non alcoholic fatty liver and its comparison with vitamin E

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014042612438N6

Enrollment

Registered

2014-08-18

Start date

2014-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non alcoholic fatty liver. Nonalcoholic fatty liver disease (NAFLD)

Interventions

control:hepatoheal tablet+vitamin E pearl.2 times in day for 4 months.

Intervention 1: intervention:hepatoheal tablet+placebo pearl.2 times in day for 4 months. Intervention 2: control:vitamin E pearl+ placebo tablet.2 times in day for 4 months. Intervention 3: control:h

Treatment - Drugs

intervention:hepatoheal tablet+placebo pearl.2 times in day for 4 months.

control:vitamin E pearl+ placebo tablet.2 times in day for 4 months.

Eligibility

Sex/Gender

All

Age

18 Years to 139 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria :Both sexes; age >18; fatty liver on ultra sound; 25< BMI<40 exclusion criteria :ast/alt<1; pregnancy; breast feeding; alcohol; hormonal disorders; other liver diseases; hepatotoxic drugs; diet or treatment for fatty liver in 3 month past; autoimmune diseases and cancers.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
ALT. Timepoint: beginning and end of study. Method of measurement: blood test.;AST. Timepoint: beginning and end of study. Method of measurement: blood test.;ALP. Timepoint: beginning and end of study. Method of measurement: blood test.	—

Secondary

Measure	Time frame
HOMA-IR. Timepoint: beginning and end of study. Method of measurement: blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.M.Taghizadeh

Kashan University of Medical Science

taghizadeh_m@kaums.ac.ir+98 36 1555 0021

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026